Connect® Myeloid Disease Registry

Sponsor
Celgene (Industry)
Overall Status
Recruiting
CT.gov ID
NCT01688011
Collaborator
(none)
2,300
229
207.6
10
0

Study Details

Study Description

Brief Summary

The purpose of the Connect® Myeloid disease registry is to provide unique insights into treatment decisions and treatment patterns as they relate to clinical outcomes of patients with myeloid diseases in routine clinical practice. This disease registry will also evaluate molecular and cellular markers that may provide further prognostic classification which may or may not be predictive of therapy and clinical outcomes.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    This Disease Registry will collect data on patient characteristics, treatment patterns and clinical outcomes. The objective is to describe how patients with myeloid diseases are treated; and to build a knowledge base regarding the effectiveness and safety of first line and subsequent treatment regimens in both community and academic settings. Enrolled patients will receive treatment and evaluations for their disease according to the standard of care and routine clinical practice at each study site. All treatments that patients receive for their disease will be recorded, including initial treatment and any subsequent therapy. Data on treatment outcomes, including response rates as measured by the treating physician, evidence of progression, survival, and patient-reported outcomes will be collected quarterly on the electronic CRF.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    2300 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Connect® Myeloid: The Myelofibrosis (MF), Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML) Disease Registry
    Actual Study Start Date :
    Dec 12, 2013
    Anticipated Primary Completion Date :
    Mar 31, 2031
    Anticipated Study Completion Date :
    Mar 31, 2031

    Arms and Interventions

    Arm Intervention/Treatment
    Newly diagnosed Lower-Risk Myelodysplastic Syndromes (LR-MDS)

    Newly diagnosed lower risk MDS patients as determined by International Prognostic Scoring System (IPSS).

    Newly diagnosed Higher-Risk Myelodysplastic Syndromes (HR-MDS)

    Newly diagnosed higher risk MDS patients as determined by International Prognostic Scoring System (IPSS).

    Newly diagnosed Acute Myeloid Leukemia (AML)

    Newly diagnosed AML patients (≥55 years old, excluding patients with acute promyelocytic leukemia (APL).

    Treated Myelofibrosis (MF)

    Newly treated MF patients receiving treatment for MF or MF-related cytopenias. This cohort also includes patients with myelodysplastic syndrome (MDS)/myeloproliferative neoplasm (MPN) overlap syndromes, excluding juvenile myelomonocytic leukemia (JMML).

    Newly diagnosed Idiopathic cytopenia of undetermined significance (ICUS)

    Newly diagnosed ICUS patients.

    Treated Lower-Risk Myelodysplastic Syndromes (LR-MDS)

    Treated LR-MDS patients receiving first active treatment regimen containing at least one non-ESA therapy

    Outcome Measures

    Primary Outcome Measures

    1. Patient Demographics- MDS/AML/ICUS Cohorts [Up to 8 years]

      Describe demographics, baseline characteristics and clinical outcomes of the patients with LR or HR MDS, ICUS, and AML.

    2. Diagnostic and Treatment Patterns- MDS/AML/ICUS Cohorts [Up to 8 years]

      Describe current and evolving patterns for diagnosis, treatment sequencing, routine clinical practice patterns and clinical outcome measures in patients with LR or HR MDS, ICUS, and AML

    3. Safety and Effectiveness- MDS/AML/ICUS Cohorts [Up to 8 years]

      Describe the survival status, clinical response to treatment, select laboratory results, occurrence of secondary primary malignancies, deaths, select adverse events.

    4. Patient Demographics- MF Cohort [Up to 5 years]

      Describe demographics, baseline characteristics, patient recorded outcomes, and clinical outcomes of patients enrolled to the MF cohort

    5. Diagnostic and Treatment Patterns- MF Cohort [Up to 5 years]

      Describe current and evolving patterns for diagnosis, treatment sequencing, routine clinical practice patterns and clinical outcome measures in patients enrolled in the MF Cohort

    6. Safety and Effectiveness- MF Cohort [Up to 5 years]

      Describe the survival status, clinical response to treatment, select laboratory results, occurrence of secondary primary malignancies, deaths, select adverse events.

    Secondary Outcome Measures

    1. Patient Reported Outcome [Up to 8 years]

      Summarize patient reported outcomes (including e.g., Health-Related Quality of Life (HRQOL)) and economic outcomes, and their association with patient characteristics, treatment regimens, and clinical outcomes

    2. Correlative Studies [Up to 8 years]

      Perform molecular and cellular correlative studies on blood/bone marrow and oral epithelial cell samples.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Patients must be able to provide written informed consent form (ICF)

    • Must be willing and able to complete baseline and follow-up HRQoL instruments, for which patients must be proficient in either English or Spanish

    • AML patients must be at least 55 years of age at the time of informed consent.

    • MF, ICUS, and MDS patients must be at least 18 years of age at the time of informed consent.

    Newly diagnosed Idiopathic Cytopenias of Undetermined Significance (ICUS), Myelodysplastic

    Syndromes (MDS), Acute Myeloid Leukemia (AML) patients:
    • Newly diagnosed primary or secondary disease. To be considered "newly diagnosed", a patient's confirmed diagnosis must be made no more than 60 days prior to the date of consent signature. (An additional 5-day window [i.e., up to 65 days prior to the date of ICF signature] may be allowed in special circumstance upon sponsor approval)

    • Cohort assignment confirmed by central eligibility review. Cohort assignment must also be confirmed by the site.

    Myelofibrosis (MF) patients:
    • Patients who initiated their first active systemic treatment for MF and/or MF-related cytopenias within 90 days prior to the date of consent signature. This cohort allows the enrollment of subjects with a diagnosis of Myelodysplastic/Myeloproliferative overlap syndromes (MDS/MPN overlap syndrome).

    • Cohort assignment is confirmed by the site. Central eligibility review is not required.

    Treated Lower-Risk Myelodysplastic Syndromes (LR-MDS) patients:
    • Patients who have initiated first active treatment regimen containing at least one non-ESA therapy, within 90 days prior to ICF

    • Cohort assignment is confirmed by site. Central eligibility review is not required.

    Exclusion Criteria:
    • Suspected or proven acute promyelocytic leukemia (APL) (FAB M3 or WHO 2008) based on morphology, immunophenotype, molecular assay or karyotype

    • Currently enrolled in any interventional clinical trial where the patient is being treated with an investigational product that cannot be identified.

    • Idiopathic Cytopenias of Undetermined Significance (ICUS), Myelodysplastic Syndromes (MDS) patients who received or are receiving active (disease modifying) therapy for the treatment of MDS prior to the date of informed consent.

    • Acute Myeloid Leukemia (AML) patients who initiated active (disease modifying treatment for AML more than 2 weeks prior to the date of consent.

    • Myelofibrosis (MF) and Myelodysplastic/Myeloproliferative (MDS/MPN) overlap syndrome patients with suspected juvenile myelomonocytic leukemia (JMML).

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 ONCOLOGY SPECIALTIES, PC - Clearview Cancer Institute Huntsville Alabama United States 35805
    2 DCH Health System (Lewis and Faye Manderson Cancer Center) Tuscaloosa Alabama United States 35404
    3 Arizona Oncology Phoenix Arizona United States 85016
    4 The University of Arizona Cancer Center Tucson Arizona United States 85719
    5 Highlands Oncology Group Fayetteville Arkansas United States 72703
    6 Mercy Hospital Fort Smith Fort Smith Arkansas United States 72903
    7 Genesis Cancer Center Hot Springs Arkansas United States 71913
    8 Clopton Clinic of Jonesboro, Inc. Jonesboro Arkansas United States 72401
    9 NEABC- Fowler Family Center for Cancer Care Jonesboro Arkansas United States 72401
    10 CARTI Little Rock Arkansas United States 72205
    11 Comprehensive Blood & Cancer Center Bakersfield California United States 93309
    12 Alta Bates Summit Comprehensive Cancer Berkeley California United States 94704
    13 Sutter East Bay Hospitals (dba Jordan Research and Education Institute - REDI) Berkeley California United States 94705
    14 John Muir Clinical Research Center Concord California United States 94520
    15 Robert A. Moss, M.D.,F AC.P, Inc Fountain Valley California United States 92708
    16 VA Central California Health Care System Fresno California United States 93703-2223
    17 Marin Cancer Care Greenbrae California United States 94904
    18 UCSD Moores Cancer Center La Jolla California United States 92093
    19 Pacific Cancer Care Monterey California United States 93940
    20 HealthCare Alliance (UHA) Pleasanton California United States 94588
    21 Mercy Cancer Center Sacramento California United States 95816
    22 St Joseph Heritage Healthcare Santa Rosa California United States 95403
    23 St. Joseph's Regional Cancer Center Stockton California United States 95204
    24 Ashwin Kashyap MD, INC. Thousand Oaks California United States 91360
    25 Saint Joseph Hospital, Cancer Centers of Colorado Denver Colorado United States 80218
    26 Regional Cancer Care Associates Manchester Connecticut United States 06040
    27 Bennett Cancer Center Stamford Hospital Stamford Connecticut United States 06904
    28 Delaware Clinical and Laboratory Physicians Christiana Delaware United States 19702
    29 MedStar Health Research Institute (Washington) Washington District of Columbia United States 20010
    30 University Cancer Institute Boynton Beach Florida United States 33426
    31 Halifax Health Center for Oncology Daytona Beach Florida United States 32114
    32 Broward Oncology Associates Fort Lauderdale Florida United States 33308
    33 Holy Cross Hospital Fort Lauderdale Florida United States 33308
    34 Southeast FL Hematology Oncology Grp Fort Lauderdale Florida United States 33308
    35 Broward Health Medical Center Fort Lauderdale Florida United States 33316
    36 University of Florida Gainesville Florida United States 32610-0278
    37 University of Florida College of Medicine Jacksonville Florida United States 32209
    38 Cancer Specialists of North Florida Jacksonville Florida United States 32256
    39 Watson Clinic Center for Cancer Care and Research Lakeland Florida United States 33805
    40 Cancer and Blood Disease Center Lecanto Florida United States 33461
    41 Ocala Oncology Ocala Florida United States 34474
    42 21st Century Oncology Orange Park Florida United States 32073
    43 Adventist Health System/Sunbelt, Inc. Orlando Florida United States 32804
    44 Memorial Healthcare System Pembroke Pines Florida United States 33028
    45 Sacred Heart Medical Oncology Group Pensacola Florida United States 32504
    46 Cancer Care Centers of Brevard Rockledge Florida United States 32955
    47 Tallahassee Memorial Cancer Center Tallahassee Florida United States 32308
    48 Space Coast Medical Associates Titusville Florida United States 32796
    49 Indian River Memorial Hospital Scully Welsh Cancer Center Vero Beach Florida United States 32960
    50 Bond Clinic Winter Haven Florida United States 33880
    51 Phoebe Putney Memorial Hospital Albany Georgia United States 31701
    52 Piedmont Cancer Institute, P.C. (was Peachtree Hematology-Oncology Consultants) Atlanta Georgia United States 30318
    53 Emory University Atlanta Georgia United States 30322
    54 Georgia Regents University Cancer Center Augusta Georgia United States 30912
    55 Southeast Georgia Health System Brunswick Georgia United States 31520
    56 Columbus Regional Research Institute Columbus Georgia United States 31904
    57 Northwest Georgia Oncology Centers, P.C. Marietta Georgia United States 30060
    58 Saint Alphonsus Regional Medical Center Boise Idaho United States 83706
    59 Hektoen Inst for Medical Resrch on behalf of itself and John H Stroger Hosp Chicago Illinois United States 60612
    60 RUSH University Cancer Center Chicago Illinois United States 60612
    61 NorthShore University Health System Evanston Illinois United States 60659
    62 Ingalls Memorial Hospital Harvey Illinois United States 60426
    63 DuPage Medical Group - Oncology (University of Rodchester) Hinsdale Illinois United States 60521
    64 Joliet Oncology Hematology Associates Ltd Joliet Illinois United States 60435
    65 Oncology Specialists, SC Niles Illinois United States 60714
    66 Illinois Cancer Care Peoria Illinois United States 61615-7828
    67 Quincy Medical Group Quincy Illinois United States 62301
    68 Edward H. KaPlan MD & Associates Skokie Illinois United States 60076
    69 Orchard Healthcare Research Inc. Skokie Illinois United States 60077
    70 Simmons Cancer Institute at Southern Illinois University Springfield Illinois United States 62702
    71 Carle Cancer Center Urbana Illinois United States 61801
    72 St. Vincent Anderson Regional Hospital Research Anderson Indiana United States 46016
    73 IU health Bloomington Hospital Bloomington Indiana United States 47402
    74 Horizon Oncology Research, Inc Lafayette Indiana United States 47905
    75 Floyd Memorial Cancer Center of Indiana New Albany Indiana United States 47150
    76 Oncology Hematology Associates of Southwest Indiana Newburgh Indiana United States 47630
    77 Northern Indiana Cancer Research Consortium South Bend Indiana United States 46628
    78 Good Samaritan Hospital - Wabash Valley Clinical Research Center Vincennes Indiana United States 47591
    79 McFarland Clinic, P.C Ames Iowa United States 50010-3014
    80 Siouxland Hematology-Oncology Associates Sioux City Iowa United States 51101
    81 Covenant Clinic Waterloo Iowa United States 50702
    82 Central Care Cancer Center Garden City Kansas United States 67846
    83 Cotton O'Neil Clinical Research/ Stormont Vail Health Topeka Kansas United States 66606
    84 Cancer Center of Kansas Wichita Kansas United States 67214
    85 Ashland-Bellefonte Cancer Center Ashland Kentucky United States 32308
    86 Baptist Health Lexington Lexington Kentucky United States 40503
    87 Baptist Health Systems, Inc., DBA Baptist Louisville Kentucky United States 40207
    88 Mary Bird Perkins Cancer Center (Baton Rouge) Baton Rouge Louisiana United States 70809
    89 Our Lady of the Lake Physician Group-Medical Oncology Baton Rouge Louisiana United States 70809
    90 Mary Bird Perkins Cancer Center at St. Tammany Covington Louisiana United States 70433
    91 QCCA - Pontchartrain Cancer Center Covington Louisiana United States 70433
    92 Maine Research Associates/Central Maine Medicine Lewiston Maine United States 04240
    93 Weinberg Cancer Institute at Franklin Square Baltimore Maryland United States 21237
    94 Center for Cancer and Blood Disorders Bethesda Maryland United States 20817
    95 Maryland Oncology Hematology Columbia Maryland United States 21044
    96 Western Maryland Health System Cumberland Maryland United States 21502
    97 UM St. Joseph's Medical Center Towson Maryland United States 21204
    98 Carroll Regional Cancer Center Westminster Maryland United States 21157
    99 Dana-Farber Cancer Institute Boston Massachusetts United States 02215
    100 Cape Cod Hospital Hyannis Massachusetts United States 02601
    101 Boone Hospital Center Columbia Michigan United States 65201
    102 Oakwood Healthcare Inc. Dearborn Michigan United States 48124
    103 John D. Dingell VA Medical Center /Cynthia Marbury Detroit Michigan United States 48201
    104 Henry Ford Health System Detroit Michigan United States 48202
    105 Detroit Clinical Research Center Farmington Hills Michigan United States 48334
    106 Genesys Hurley Cancer Institute Flint Michigan United States 48503
    107 Cancer and Hematology Centers of Western Michigan Grand Rapids Michigan United States 49503
    108 Ascension St. John Hospital_Hematology (was St. Johns Hospital and Hematology-Oncology Associates East PC ) Grosse Pointe Woods Michigan United States 48236
    109 West Michigan Cancer Center Kalamazoo Michigan United States 49007
    110 Michigan State University/Breslin Cancer Center Lansing Michigan United States 48910
    111 St. John Providence Hospital System Southfield Michigan United States 48075
    112 Togus Va Medical Center Augusta Minnesota United States 04330
    113 Essentia Health Oncology Clinical Trials Duluth Minnesota United States 55805
    114 Southdale Cancer Clinic Edina Minnesota United States 55435
    115 Metro MN CCOP/Park Nicollet Institute Saint Louis Park Minnesota United States 55416
    116 Metro MN CCOP/Park Nicollet Institute Saint Louis Park Minnesota United States 55426
    117 Hattiesburg Clinic Hematology/Oncology Hattiesburg Mississippi United States 39401
    118 MCDA - Central Care Center Bolivar Missouri United States 65613
    119 Southeast Cancer Center Cape Girardeau Missouri United States 63703
    120 Harry S Truman Memorial Veterans' Hospital Columbia Missouri United States 65201
    121 Columbia Comprehensive Cancer Care Clinic Jefferson City Missouri United States 65109
    122 Mercy Cancer Center - Joplin Joplin Missouri United States 64804
    123 Kansas City Veterans Affairs Medical Center Kansas City Missouri United States 64128
    124 Research Medical Center Kansas City Missouri United States 64132
    125 Heartland Regional Medical Center (Heartland Health) Saint Joseph Missouri United States 64507
    126 Missouri Baptist Medical Center Saint Louis Missouri United States 63131
    127 Mercy Cancer - St. Louis Saint Louis Missouri United States 63141
    128 Mercy Research - Springfield Springfield Missouri United States 65804
    129 Billings Clinic Billings Montana United States 59101
    130 St. Vincent Frontier Cancer Center Billings Montana United States 59102
    131 Montana Cancer Institute Foundation Missoula Montana United States 59802
    132 Southeast Nebraska Cancer Center Lincoln Nebraska United States 68510
    133 Southern Nevada Cancer Research Foundation Las Vegas Nevada United States 89106
    134 Renown Regional Medical Center Reno Nevada United States 89502
    135 VA Medical Center Manchester Manchester New Hampshire United States 03104
    136 Englewood Hospital and Medical Center Englewood New Jersey United States 07631
    137 John Theurer Cancer Center (Hackensack U Med Center) Hackensack New Jersey United States 07601
    138 Hematology-Oncology Associates of Northern New Jersey Morristown New Jersey United States 07962
    139 Saint Peter's University Hospital New Brunswick New Jersey United States 08859
    140 St Joseph Healthcare System Paterson New Jersey United States 07503
    141 Somerset Medical Center 110 Rehill Avenue Somerville New Jersey United States 08876
    142 Sparta Cancer Center Sparta New Jersey United States 07871
    143 Albert Einstein College of Medicine - Montefiore Medical Center Bronx New York United States 10461
    144 New York Cancer and Blood Specialists Bronx New York United States 10469
    145 Maimonides Cancer Center Brooklyn New York United States 11220
    146 Bassett Heathcare Network Cooperstown New York United States 13326
    147 Hematology Oncology Associates of Central NY East Syracuse New York United States 13057
    148 C.R. Wood Cancer Center at Glens Falls Hospital Glens Falls New York United States 12801
    149 Huntington Medical Group Huntington Station New York United States 11746
    150 Weill Cornell Medical College New York New York United States 10065
    151 Rochester General Hospital Rochester New York United States 14621
    152 University of Rochester ~ Wilmot Cancer Institute Rochester New York United States 14642
    153 St. Francis Hospital Roslyn New York United States 11576
    154 New York Medical College Valhalla New York United States 10595
    155 Ccs Oncology Williamsville New York United States 14221
    156 Leo W Jenkins Cancer Center Greenville North Carolina United States 27834
    157 Kinston Medical Specialists Kinston North Carolina United States 28501
    158 Wake Forest Baptist Health Winston-Salem North Carolina United States 27157
    159 Summa Health System Akron Ohio United States 44304
    160 Gabrail Cancer Center Research Canton Ohio United States 44718
    161 TriHealth, Good Samaritan Hospital Cincinnati Ohio United States 45220
    162 University Hospitals, Case Medical Center Cleveland Ohio United States 44106
    163 Cleveland Clinic Foundation Cleveland Ohio United States 44195
    164 Mid Ohio Oncology/Hematology, Inc., dba The Mark H. Zangmeister Center Columbus Ohio United States 43219
    165 Dayton Physicians Kettering Ohio United States 45409
    166 University of Toledo Medical Center (Utmc) Toledo Ohio United States 43614
    167 INTEGRIS Cancer Institute Southwest Medical Center Oklahoma City Oklahoma United States 73109
    168 INTEGRIS Cancer Institute of Oklahoma Proton Campus Oklahoma City Oklahoma United States 73142
    169 Oklahoma Cancer Specialist and Research Institute Tulsa Oklahoma United States 74146
    170 Good Samaritan Hospital Corvallis Corvallis Oregon United States 97330
    171 Providence Cancer Center Portland Oregon United States 97213
    172 Salem Health Salem Oregon United States 97305
    173 Consultants in Medical Oncology and Hematology Drexel Hill Pennsylvania United States 19026-1129
    174 Hematology and Oncology Assoc of NEPA Dunmore Pennsylvania United States 18512
    175 Lancaster Cancer Center Lancaster Pennsylvania United States 17554
    176 Lancaster General Hospital Lancaster Pennsylvania United States 17604
    177 Allegheny Singer Research Institute (was West Penn Hospital) Pittsburgh Pennsylvania United States 15211
    178 University of Pittsburgh Cancer Institute Pittsburgh Pennsylvania United States 15213
    179 Reading Hospital - McGlinn Cancer Institute West Reading Pennsylvania United States 19611
    180 Cancer Care Associates of York York Pennsylvania United States 17403
    181 Roger Williams Medical Center Providence Rhode Island United States 02908
    182 Charleston Hematology Oncology Associates, PA Charleston South Carolina United States 29414
    183 Prisma Health Cancer Institute - Upstate Greenville South Carolina United States 29605
    184 Spartanburg Regional Medical Center Spartanburg South Carolina United States 29303
    185 Prairie Lakes Health Systen, Inc Watertown South Dakota United States 57201
    186 Thompson Cancer Survival Center Knoxville Tennessee United States 37916
    187 University of Tennessee Medical Center Cancer Intitute Knoxville Tennessee United States 37920
    188 Vanderbilt-Ingram Cancer Center Nashville Tennessee United States 37232
    189 Hendrick Cancer Center Abilene Texas United States 79601
    190 BSL Health System (Harrington Cancer Center) Amarillo Texas United States 79015
    191 Texas Oncology, Amarillo Cancer Center Amarillo Texas United States 79106
    192 Coastal Bend Cancer Center Corpus Christi Texas United States 78404
    193 Christus Spohn Cancer Center Corpus Christi Texas United States 78405
    194 Dallas VA Medical Center Dallas Texas United States 75216
    195 HOLD - Texas Oncology, Dallas Dallas Texas United States 75230
    196 Texas Oncology - Sammons Cancer Center Dallas Texas United States 75246
    197 Texas Oncology - Fort Worth Cancer Center Fort Worth Texas United States 76104
    198 UTMB Galveston Galveston Texas United States 77573
    199 Oncology and Hematology of South Texas, PA Laredo Texas United States 78041
    200 Southwest Cancer Treatment & Research Center Lubbock Texas United States 79415
    201 Texas Oncology, McAllen (plus 2 satelite sites) McAllen Texas United States 78503
    202 Texas Oncology, Midland Midland Texas United States 79701
    203 Scott & White Healthcare Round Rock Texas United States 78665
    204 Baylor Research Institute dba Scott & White Memorial Hospital Temple Texas United States 76508
    205 Blood and cancer Center of East Texas Tyler Texas United States 75701
    206 Community Cancer Trials of Utah Ogden Utah United States 84403
    207 Foley Cancer Center/RRMC Rutland Vermont United States 05701
    208 VA Medical Center - White River Junction White River Junction Vermont United States 05009
    209 Lynchburg Hematology Oncology Clinic Lynchburg Virginia United States 24501
    210 Peninsula Cancer Institute Newport News Virginia United States 23601
    211 PeaceHealth St Joseph Cancer Center Bellingham Washington United States 98225
    212 Providence Regional Cancer Partnership Everett Washington United States 98201
    213 Kadlec Regional Medical Center (KRMC) Kennewick Washington United States 99336
    214 Vista Oncology Inc. PS Olympia Washington United States 98502
    215 Benaroya Research Institute at Virginia Mason Seattle Washington United States 98101
    216 Swedish Cancer Institute Seattle Washington United States 98104
    217 Providence St. Mary Regional Cancer Center Walla Walla Washington United States 99362
    218 West Virginia University Morgantown West Virginia United States 26506
    219 St. Vincent Hospital Green Bay Wisconsin United States 54301
    220 Bellin Memorial Hospital/ Bellin Cancer Team Green Bay Wisconsin United States 54313
    221 Gundersen Lutheran Inc La Crosse Wisconsin United States 54601
    222 Froedtert & Medical College of Wisconsin CLCC Milwaukee Wisconsin United States 53150
    223 Columbia St. Mary'S Milwaukee Wisconsin United States 53211
    224 Wheaton Franciscan Cancer Care - All Saints Racine Wisconsin United States 53405
    225 Waukesha Memorial Hospital Waukesha Wisconsin United States 53188
    226 Memorial Hospital of Laramie County dba Cheyenne Regional Medical Center Cheyenne Wyoming United States 82001
    227 Puerto Rico Hematology Oncology Group Bayamon Puerto Rico 00961
    228 VA Caribbean Healthcare System CRADA San Juan Puerto Rico 00683
    229 Fundacion de lnvestigaci6n San Juan Puerto Rico 00927

    Sponsors and Collaborators

    • Celgene

    Investigators

    • Study Director: Bristol-Myers Squibb, Bristol-Myers Squibb

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Celgene
    ClinicalTrials.gov Identifier:
    NCT01688011
    Other Study ID Numbers:
    • AZA-MDS-006
    • Connect® MDS/AML Registry
    First Posted:
    Sep 19, 2012
    Last Update Posted:
    Aug 23, 2022
    Last Verified:
    Aug 1, 2022

    Study Results

    No Results Posted as of Aug 23, 2022